Androulla N Miliotou

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Replacement Therapy

Protein Protein

Pluripotent Stem Cells

Top Venues

Current medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Androulla N Miliotou, Parthena F Foltopoulou, Alexandra Ingendoh-Tsakmakidis, Asterios S Tsiftsoglou, Ioannis S Vizirianakis, Ioannis S Pappas, Lefkothea C Papadopoulou
Protein Transduction Domain-Mediated Delivery of Recombinant Proteins and In Vitro Transcribed mRNAs for Protein Replacement Therapy of Human Severe Genetic Mitochondrial Disorders: The Case of Sco2 Deficiency. Pharmaceutics 15 (1) (2023)
Androulla N Miliotou, Parthena F Foltopoulou, Alexandra Ingendoh-Tsakmakidis, Asterios S Tsiftsoglou, Ioannis S Vizirianakis, Ioannis S Pappas, Lefkothea C Papadopoulou
Protein Transduction Domain-Mediated Delivery of Recombinant Proteins and In Vitro Transcribed mRNAs for Protein Replacement Therapy of Human Severe Genetic Mitochondrial Disorders: The Case of Sco2 Deficiency. Pharmaceutics 15 (1) (2023)
Androulla N Miliotou, Parthena F Foltopoulou, Alexandra Ingendoh-Tsakmakidis, Asterios S Tsiftsoglou, Ioannis S Vizirianakis, Ioannis S Pappas, Lefkothea C Papadopoulou
Protein Transduction Domain-Mediated Delivery of Recombinant Proteins and In Vitro Transcribed mRNAs for Protein Replacement Therapy of Human Severe Genetic Mitochondrial Disorders: The Case of Sco2 Deficiency. Pharmaceutics 15 (1) (2023)
Ioannis D Karantas, Androulla N Miliotou, Panoraia I Siafaka
An updated review for hyperuricemia and gout management; special focus on the available drug delivery systems and clinical trials. Current medicinal chemistry (2023)